AT56856B - Process for the manufacture of cholesterol preparations suitable for injection. - Google Patents

Process for the manufacture of cholesterol preparations suitable for injection.

Info

Publication number
AT56856B
AT56856B AT56856DA AT56856B AT 56856 B AT56856 B AT 56856B AT 56856D A AT56856D A AT 56856DA AT 56856 B AT56856 B AT 56856B
Authority
AT
Austria
Prior art keywords
cholesterol
injection
manufacture
preparations suitable
esters
Prior art date
Application number
Other languages
German (de)
Original Assignee
Farbenfab Vorm Bayer F & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farbenfab Vorm Bayer F & Co filed Critical Farbenfab Vorm Bayer F & Co
Application granted granted Critical
Publication of AT56856B publication Critical patent/AT56856B/en

Links

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Herstellung von zur Injektion geejgneten Cholesterinpräparaten. 



   Wie aus der neueren Literatur hervorgeht, liegt in der therapeutischen Praxis das Bedürfnis vor, Cholesterin in zu Injektionen geeignete Lösungen zu bringen (vergl. Grimm, Deutsche med. Wochenschrift" 1910, Seite 176). Das einzige, bisher in Betracht kommende Lösungsmittel für Cholesterin ist   Olivenöl,   dessen Lösungsvermögen jedoch so gering ist, dass man nicht mehr als etwa   3"/oige Losungen damit   erhalten kann (vergl. Morgenroth und Reicher, Charité-Annalen 33, Separat Seite 2). 



   Es wurde nun gefunden, dass die Ester höherer Fettsäuren, das Olivenöl inbegriffen, schon in sehr geringen Mengen das Vermögen besitzen, den Schmelzpunkt der physiologisch wichtigen Cholesterinester (vergl. Hoppe-Seylers Zeitschrift für physiologische Chemie", Bd. 21, Seite 331 u.   ff.)   so stark herabzndrücken, dass derartige Gemische unter Körpertemperatur zu vollkommen klaren, homogenen Flüssigkeiten schmelzen und, einmal ge-   schmolzen,   längere Zeit bei Zimmertemperatur flüssig bleiben. Auf diese Weise lassen sich Präparate erhalten, mittels deren dem Körper grössere Mengen Cholesterin subkutan oder per os zugeführt worden können, ohne dass er durch indifferente Stoffe unnötig belastet wird. 



   Eine innige Mischung von 2 Teilen   Cholesterinölsäureester   mit 1 Teil Ölsäureäthylester beginnt bei 290 C zu schmelzen, eine solche mit 1 Teil   Palmitinsäuremethylester   bei 310, während der reine Cholesterinölsäureester bei 40 bis 45  schmilzt. Als brauchbar für den vorgenannten Zweck erweisen sich auch Mischungen von   Cholesterinölsäureester   mit Olivenöl oder Phenylpalmitat. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 



  Process for the manufacture of cholesterol preparations suitable for injection.



   As can be seen from the recent literature, there is a need in therapeutic practice to bring cholesterol into solutions suitable for injections (cf. Grimm, Deutsche med. Wochenschrift "1910, page 176). The only solvent for cholesterol that has been considered so far is olive oil, but its dissolving power is so low that you cannot get more than about 3% solutions with it (cf. Morgenroth and Reicher, Charité-Annalen 33, separate page 2).



   It has now been found that the esters of higher fatty acids, including olive oil, have the ability, even in very small quantities, to reduce the melting point of the physiologically important cholesterol esters (cf. Hoppe-Seylers Zeitschrift für Physiologische Chemie ", Vol. 21, Page 331 u. ff.) so much that such mixtures melt into completely clear, homogeneous liquids below body temperature and, once melted, remain liquid for a long time at room temperature. In this way, preparations can be obtained which give the body larger amounts of cholesterol subcutaneously or can be supplied per os without being unnecessarily burdened by indifferent substances.



   An intimate mixture of 2 parts of cholesterol oleic acid ester with 1 part of oleic acid ethyl ester begins to melt at 290 ° C., one with 1 part of palmitic acid methyl ester at 310 ° C., while the pure cholesterol oleic acid ester melts at 40 to 45 ° C. Mixtures of cholesterol oleic acid esters with olive oil or phenyl palmitate also prove to be useful for the aforementioned purpose.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATENT-ANSPRUCH : Verfahren zur Herstellung von zur Injektion geeigneten Cholesterin präparaten, dadurch gekennzeichnet, dass man Ester höherer Fettsäuren mit Cholesterinestern zusammenschmilzt. **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATENT CLAIM: Process for the production of cholesterol preparations suitable for injection, characterized in that esters of higher fatty acids are melted together with cholesterol esters. ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT56856D 1910-06-10 1911-04-28 Process for the manufacture of cholesterol preparations suitable for injection. AT56856B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE56856X 1910-06-10

Publications (1)

Publication Number Publication Date
AT56856B true AT56856B (en) 1912-12-27

Family

ID=5628939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT56856D AT56856B (en) 1910-06-10 1911-04-28 Process for the manufacture of cholesterol preparations suitable for injection.

Country Status (1)

Country Link
AT (1) AT56856B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2675342A (en) * 1950-09-30 1954-04-13 Schering Corp Supersaturated oil solutions of steroid hormones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2675342A (en) * 1950-09-30 1954-04-13 Schering Corp Supersaturated oil solutions of steroid hormones

Similar Documents

Publication Publication Date Title
DE2938807A1 (en) FAT EMULSION AND THEIR USE
DE2324717B2 (en) Process for the production of a stable AHF concentrate (factor VUI)
AT56856B (en) Process for the manufacture of cholesterol preparations suitable for injection.
DE2937290A1 (en) ETOMIDATE INCLUDING INJECTION PREPARATIONS FOR INTRAVENOUS TRACKING
CH497898A (en) Solubilisers for narcotically-active phenoxyacetic acid
DE236080C (en)
DE696594C (en) Process for the production of highly concentrated injection solutions of fat-soluble hormones or their derivatives
DE2255153A1 (en) NEW STEROID COMPOUNDS, METHODS OF MANUFACTURING AND USING THEM
US1034161A (en) Cholesterin preparation.
DE415227C (en) Process for the production of durable, oily emulsions of bismuth salts
AT21681B (en) Process for the production of bromolecithin.
DE352364C (en) Process for the production of oily medical solutions
DE940402C (en) Process for the preparation of a 4-pregnen-17ª ‡, 21-diol-3, 11, 20-trione ester or its solutions or suspensions
DE498433C (en) Process for the preparation of therapeutically valuable compounds from esters of p-aminobenzoic acid and camphor
DE297084C (en)
DE2064373C3 (en) Meltable coating agents, in particular for food and pharmaceutical preparations
DE975951C (en) Process for the production of new, depot-effective steroid hormone esters of oily consistency suitable for injection purposes
DE164128C (en)
DE188434C (en)
DE656989C (en) Process to increase the solubility of cinnamic acid
AT202703B (en) Process for the production of highly concentrated oily injection solutions
DE384688C (en) Process for the preparation of durable guaiacol preparations in aqueous solution
AT146940B (en) Process for the preparation of compounds from therapeutically effective essential oils and organic acids.
DE416982C (en) Method of killing bed bugs
AT216687B (en) Process for the manufacture of testosterone derivatives